Bioteknologian ja molekulaarisen lääketieteen laitos
Department of Biotechnology and Molecular Medicine

Julkaisut 2006
Publications 2006

Lisätietoja julkaisusta saa klikkaamalla sen numeroa.
For full details, please click the number in front of the publication.


1 Aarnisalo AA et al. Efficacy of gene transfer through the round window membrane: an in vitro model.
2 Degenhardt T et al. The insulin-like growth factor-binding protein 1 gene is a primary target of peroxisome proliferator-activated receptors.
3 Deiner C et al. Adventitial VEGF(165) gene transfer prevents lumen loss through induction of positive arterial remodeling after PTCA in porcine coronary arteries.
4 Drossou A et al. Ontogenetic development of the proteolytic digestion activities in larvae of Oreochromis niloticus fed with different diets.
5 Gruchala M et al. Gene therapy for cardiovascular diseases.
6 Hedman M et al. New technologies in cardiovascular research gene therapy.
7 Heinonen M et al. Adipokiinit - rasvakudoksen viestinviejistä valoa lihavuuden haittojen ymmärtämiseen. Pitäisikö rasvakudosta kohdella kuin endokriinista kasvainta?
8 Hernesniemi J et al. Principles of microneurosurgery for safe and fast surgery.
9 Hyvönen MT et al. Activated polyamine catabolism in acute pancreatitis. Alpfa-methylated polyamine analogues prevent trypsinogen activation and pancreatitis-associated mortality .
10 Hyvönen MT et al. Polyamine-regulated unproductive splicing and translation of spermidine/spermine N1 -acetyltransferase.
11 Höytö A et al. Modest increase in temperature affects ODC activity in L929 cells: low-level radiofrequency radiation does not.
12 Jansen JFA et al. Stem cell profiling by nuclear magnetic resonance spectroscopy.
13 Jänne J et al. Genetic engineering of polyamine catabolism in transgenic mice and rats.
14 Jänne J et al. Genetic manipulation of polyamine catabolism in rodents.
15 Järvinen A et al. Guide molecule-driven stereospecific degradation of alpha-methylpolyamines by polyamine oxidase.
16 Järvinen AJ et al. Alpha-methyl polyamines: efficient synthesis and tolerance studies in vivo and in vitro. First evidence for dormant stereospecificity of polyamine oxidase.
17 Kaikkonen MU et al. Truncated vesicular stomatitis virus G protein improves baculovirus transduction efficiency in vitro and in vivo.
18 Karpanen T et al. Lymphangiogenic growth factor responsiveness is modulated by postnatal lymphatic vessel maturation.
19 Keinänen R et al., ed. The Eleventh Annual Post-Graduate Symposium of the A.I. Virtanen Institute Graduate School. AIVI Winter School 2006. Abstracts.
20 Kiehne K et al. Defensin expression in chronic pouchitis in patients with ulcerative colitis or familial adenomatous polyposis coli.
21 Kinnunen K et al. Overexpression of VEGF-A induces neovascularization and increased vascular leakage in rabbit eye after intravitreal adenoviral gene transfer.
22 Laitinen I et al. Non-specific binding of [(18)F]FDG to calcifications in atherosclerotic plaques: experimental study of mouse and human arteries.
23 Landar A et al. Induction of the permeability transition and cytochrome c release by 15-deoxy-delta12,14-prostaglandin J2 in mitochondria.
24 Lehmusvaara S et al. Utility of cell-permeable peptides for enhancement of virus-mediated gene transfer to human tumor cells.
25 Leppänen P et al. Short and long-term effects of hVEGF-A165 in Cre-activated transgenic mice.
26 Liimatainen T et al. Ultra-short echo time spectroscopic imaging in rats: implications for monitoring lipids in glioma gene therapy.
27 Liimatainen T et al. Identification of mobile cholesterol compounds in experimental gliomas by (1)H MRS in vivo: Effects of ganciclovir-induced apoptosis on lipids.
28 Linnankivi T et al. Cerebroretinal microangiopathy with calcifications and cysts.
29 Lisowska A et al. Unresponsive or non-compliant steatorrhea in cystic fibrosis?
30 Mäkinen PI et al. Stable RNA interference: comparison of U6 and H1 promoters in endothelial cells and in mouse brain.
31 Mäntylä T et al. Targeted magnetic resonance imaging of Scavidin-receptor in human umbilical vein endothelial cells in vitro.
32 Mättö M et al. hCAR-EGFP fusion receptor in human follicular lymphoma B cells - A model for adenoviral gene therapy for B cell malignancies.
33 Määttä A-M et al. Transcriptional targeting of virus-mediated gene transfer by the human hexokinase II promoter.
34 Niiranen K. Consequences of Spermine Synthase or Spermidine/Spermine N1-acetyltransferase deficiency in polyamine metabolism. Studies with Gene-Disrupted Mouse Embryonic Stem Cells and Mice.
35 Niiranen K et al. Mice with targeted disruption of spermidine/spermine N1-acetyltransferese gene maintain nearly normal tissue polyamine homeostasis but show signs of insulin resistance upon aging.
36 Nälsén C et al. Dietary (n-3) fatty acids reduce plasma F2-isoprostanes but not prostaglandin F2alfa in healthy humans.
37 Pelli H et al. Duodenal diazepam-binding protein expression and plasma cholecystokinin after alcoholic pancreatitis.
38 Pietilä M. Polyamiinien merkitys keratinosyyttien erilaistumisessa.
39 Pulkkanen KJ, Yla-Herttuala S. Adenovirus-mediated HSV-tk gene therapy for malignant glioma: Clinical experience.
40 Pätilä T et al. Vascular endothelial growth factor C-induced collateral formation in a model of myocardial ischemia.
41 Rautsi O et al. Type I interferon response against viral and non-viral gene transfer in human tumor and primary cell lines.
42 Roy H. Vascular Endothelial Growth Factors (VEGFs). Role in Perivascular Therapeutic Angiogenesis and Diabetic Macrovascular Disease.
43 Roy H et al. VEGF-A, VEGF-D, VEGF receptor-1, VEGF receptor-2, NF-kappaB, and RAGE in atherosclerotic lesions of diabetic Watanabe heritable hyperlipidemic rabbits.
44 Roy H et al. VEGF-A, VEGF-D, VEGF receptor-1, VEGF receptor-2, NF-kappaB, and RAGE in atherosclerotic lesions of diabetic Watanabe heritable hyperlipidemic rabbits [FJ Express Full-Length Article].
45 Roy H et al. Biology of vascular endothelial growth factors.
46 Räty J. Baculovirus Surface Modifications for Enhanced Gene Delivery and Biodistribution Imaging.
47 Räty JK et al. Magnetic resonance imaging of viral particle biodistribution in vivo.
48 Saaristo A et al. Vascular endothelial growth factor-C accelerates diabetic wound healing.
49 Sallinen H et al. A highly reproducible xenograft model for human ovarian carcinoma and application of MRI and ultrasound in longitudinal follow-up.
50 Turunen P et al. Extracellular superoxide dismutase with vaccinia virus anti-inflammatory protein 35K or tissue inhibitor of metalloproteinase-1: Combination gene therapy in the treatment of vein graft stenosis in rabbits.
51 Tyynelä K. Gene Therapy of Malignant Glioma. Experimental and Clinical Studies.
52 Wahlfors T. Enhancement of HSV-TK/GCV Suicide Gene Therapy of Cancer.
53 Wahlfors T et al. In vivo enhancement of herpes simplex virus thymidine kinase/ganciclovir cancer gene therapy with polyamine biosynthesis inhibition.
54 Wahlfors T et al. Polyamine depletion and cell cycle manipulation in combination with HSV thymidine kinase/ganciclovir cancer gene therapy.
55 Walkowiak J et al. Normal pancreatic secretion in childreen with progressive familial intrahepatic cholestasis type 1.
56 Walkowiak J et al. Exocrine pancreatic function in children with progressive familial intrahepatic cholestasis type 2.
57 Wirth T et al. Safety profile of plasmid/liposomes and virus vectors on clinical gene therapy.
58 Wirth T, Ylä-Herttuala S. Gene technology based therapies in the brain.
59 Ylä-Herttuala S. An update on angiogenic gene therapy: Vascular endothelial growth factor and other directions.
60 Ylä-Herttuala S, Salo M. Periytyvien tautien hoito.

Bioteknologian ja molekulaarisen lääketieteen laitos Department of Biotechnology and Molecular Medicine
Julkaisutietokanta 15.4.2008 Publications Data Base 15.4.2008